Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Part 2: How is hepatitis C treated?
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Strategies to Secure Access to Generic HCV Medicines
Read More
Story from Ayu Oktariani, Bandung, Indonesia
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
